Development of Bing-Neel syndrome Despite Ibrutinib Therapy for Waldenstrom Macroglobulinemia: Next Steps in Management and Review of Future Directions

Autor:	Lukas Delasos, Nishka Shetty, James J. Vredenburgh, Melissa Sepulveda-Ramos, Deep Phachu
Rok vydání:	2020
Předmět:	Clinical trial medicine.medical_specialty chemistry.chemical_compound chemistry business.industry Ibrutinib Medicine Waldenstrom macroglobulinemia Disease business Intensive care medicine medicine.disease Bing–Neel syndrome
DOI:	10.22541/au.158938204.49606817
Popis:	Bing-Neel syndrome (BNS) remains a rare complication of Waldenstrom Macroglobulinemia. Given the paucity of this disease, treatment guidelines are based on small clinical trials with limited participants. Here we present a case of BNS that developed while on ibrutinib therapy, followed by a review of the next steps in management.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::516f4cca035dbe5542452e534467bbb6 https://doi.org/10.22541/au.158938204.49606817 Zobrazit plný text záznamu